Apollo Hospitals share price today

Apollo Hospitals Enterprise Ltd's share price was ₹8,599.50 at the close on 4 November 2026. It has been rising for 34 weeks. That is 5.4% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹6,803 and ₹8,957, and at that close it sat 83% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Apollo Hospitals Enterprise Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 2 weeks in a row.

Over the last 11 years the share price moved +500% while the NIFTY 500 moved +257%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 11 quarters in a row (every quarter we can compare), profit up on a year earlier for 11 quarters in a row (every quarter we can compare) and best operating margin in 15 quarters.

1. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹7,044 crore, +20.6% on a year earlier.

   Why: Revenue rose because more patients came to its hospitals and each patient spent more on care.

   Next results: check whether hospital revenue growth stays on track for 20 percent.

   From the earnings call on 13 Aug 2026.

2. Profit up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter profit was ₹610 crore, +38.3% on a year earlier.

   Why: Profit rose because established hospitals made a higher margin on their revenue.

   Next results: check whether the digital and insurance businesses stop losing money.

   From the earnings call on 13 Aug 2026.

3. Best operating margin in 15 quarters

   Operating margin was 16% in the June 2026 quarter, against 15% a year earlier.

   Why: Margin rose because more patients came in and each patient spent more, which helped cover fixed costs.

   From the earnings call on 13 Aug 2026.

For April to June 2026 (the quarter ended 30 June 2026), Apollo Hospitals reported revenue of ₹7,044 crore, up 20.6% from ₹5,842 crore a year earlier, and a profit of ₹610 crore, up 38.3% from ₹441 crore.

Apollo Hospitals results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Apollo Hospitals' management discussed these results on a call held on 13 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Apollo Hospitals closed at ₹8,599.50 on 4 November 2026, up 12.5% from ₹7,642.00 a year earlier (7 November 2025) and up 93.7% over five years. Its highest weekly close since February 2016 was ₹8,957.00 on 31 July 2026.

Apollo Hospitals share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

566 weekly closes from 26 February 2016 to 4 November 2026.

4 Nov 2026: Apollo Hospitals closed at ₹8,599.50, up 1.8% on the week and up 5.7% on the month. 14 Aug 2026: ex-date for a dividend of ₹10 a share.

Earlier

• 13 Aug 2026: Apollo Hospitals held its results call for April to June 2026. Management guided: FY27 hospital revenue growth 18-20%, with management saying it is on track for 20%.
• Results for April to June 2026: Revenue up 20.6% and profit up 38.3% on a year earlier.
• 16 Feb 2026: ex-date for an interim dividend of ₹10 a share.

Apollo Hospitals paid ₹20 a share in regular dividends in the 12 months to 5 November 2026 (2 payments), a yield of 0.23% at the ₹8,599.50 close on 4 November 2026. The last was a dividend of ₹10 a share, ex-date 14 August 2026.

Apollo Hospitals dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Apollo Hospitals Enterprise Ltd paid out 15% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 13 August 2026, Apollo Hospitals' management guided: FY27 hospital revenue growth 18-20%, with management saying it is on track for 20%.

“Yes, for this, yes, I believe we're on track to deliver 20%.”Suneeta Reddy, Managing Director, on the call for April to June 2026

What management guided

• FY27 new-hospital operating profit loss maintained at ₹150 crore; quarterly run-rate expected to rise by at least ₹20 crore before easing.
• Gurgaon soft launch September, opening October, meaningful inpatient contribution from Q4; total capacity reaches 14,100 beds by FY31, with current overhead supporting 750 beds.
• Digital vertical poised for breakeven next quarter; sustainable expenses around ₹80 crore per quarter; insurance planned to break even by end-Q3.
• Established hospitals guided to 13-14% revenue growth, new units adding 7% over the next two years; margins to sustain current levels and improve somewhat.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 13 August 2026.

What is changing at Apollo Hospitals, from the latest results and calls: established-hospital growth and operating leverage, complex-care mix and pricing and healthco and digital cost inflection.

• Established-hospital growth and operating leverage. Hospital services grew through volume, acuity, pricing, and productivity, with management aiming for continued established-hospital growth. ⚠ estimate
• Complex-care mix and pricing. Healthcare services reported higher acuity volumes, an increase in revenue per patient, and annual pricing provisions. ⚠ estimate
• HealthCo and digital cost inflection. HealthCo expanded profit while digital remains planned for cash breakeven in the next reported quarter. ⚠ estimate
• Diagnostics-led AHLL improvement. Diagnostics growth and margin progression are the stated route to AHLL improvement. ⚠ estimate

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the latest results, written 22 August 2026.

The thesis breaks if hospital revenue misses the guided range while operating margin falls below the prior-year level and the delayed Gurgaon opening slips again.

Each change stops working if

• Established-hospital growth and operating leverage: Established-hospital growth slows while new-hospital losses rise before utilization improves.
• Complex-care mix and pricing: Complex-care volumes or pricing resets slow before replacement capacity contributes.
• HealthCo and digital cost inflection: Digital cash breakeven does not occur in the next quarter or insurance costs increase again.
• Diagnostics-led AHLL improvement: Diagnostics growth falls below management’s stated goal or AHLL margin does not progress.

The main risks

• Gurgaon commissioning delay: Gurgaon has moved from an earlier operationalization date to the fourth quarter of the fiscal year. ⚠ estimate
• Digital breakeven slips again: Digital breakeven is now expected in the upcoming quarter after prior timing changes. ⚠ estimate
• Working-capital cycle lengthens during capital spending: Cash conversion remains above reported profit, but the cash conversion cycle moved from negative to positive days. ✓ fact

Our read after the latest results, written 22 August 2026.

When Apollo Hospitals reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Digital vertical cash breakeven in the upcoming quarter - test whether insurance build-out and one-time costs stop delaying standalone economics.

Apollo Hospitals is on one of our India lists: Nifty 50 companies.

Apollo Hospitals Enterprise Ltd earned ₹610 Cr of net profit in the Jun 2026 quarter, +38.3% on the same quarter a year earlier. That is the 11th quarter in a row of profit growth. Full-year FY26 profit was ₹2,003 Cr. Over 10 years profit has grown 23.9% a year on average. That is 8.7% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹441 Cr.

For the full year, FY26 profit was ₹2,003 Cr (+33.1% on the year before).

Why profit moved: revenue changed +20.6% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +33.0% and revenue +17.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Apollo Hospitals Enterprise Ltd reported ₹7,044 Cr of revenue in the Jun 2026 quarter, +20.6% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 10 years it has grown 15.2% a year on average. The last full year, FY26, came in at ₹25,228 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. AHLL reported revenue growth, higher EBITDA, and a narrower profit loss. Management identifies diagnostics as the principal source of margin expansion and has narrowed focus toward diagnostics and primary care.

The last four reported quarters add to ₹26,431 Cr.

FY26 revenue was ₹25,228 Cr, +15.8% on the year before.

Recent pace: the last four quarters grew +17.2% on average, against 15.2% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +17.2%, against +15.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +33.2%, against +42.0% a year (rolling over).

Apollo Hospitals Enterprise Ltd's operating margin was 16.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 10.0% and 16.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. The operating-leverage catapult applies because management attributes margin improvement to operating leverage, clinical case mix, and productivity optimization. The latest quarter also shows a higher operating margin than the comparable quarter. The off-switch is a failure of established-hospital growth to offset start-up losses from new units.

Why the margin moved: operating margin changed +0.9 percentage points on the year while gross margin changed +1.1 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 156% of Apollo Hospitals Enterprise Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹2,856 Cr of operating cash against ₹2,003 Cr of profit. After ₹2,271 Cr of spending on assets, ₹585 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 156% of profit came in as cash: the cash cycle got 15 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 2.8× depreciation over three years. The next section checks what that spending is building.

Apollo Hospitals Enterprise Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 3 days in FY26, up from −12 days in FY21. It spent ₹6,495 Cr on assets over the last 3 years. Customers take 50 days to pay, and stock sits for 15 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹25,228 Cr, each day of that cycle ties up about ₹69.1 Cr, so roughly ₹207 Cr is tied up in the business at any time.

FY26: customers took 50 days to pay and stock sat for 15 days, about 0.5 months of sales sitting as stock, for a full cycle of 3 days, longer than FY21's −12.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 15 days. Customers pay about 50 days after that. Suppliers are paid at 63 days. Together that makes the 3-day cycle.

Spending on assets: ₹6,495 Cr over the last 3 years, against ₹2,321 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹1,032 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Apollo Hospitals Enterprise Ltd's P/E is 58.7×, near the low end of its own history: it has been lower only 6% of the time. Its usual P/E (the middle reading) is 75.2×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.